ICON Executive and Leadership Team

Thomas Marsland, the President at ICON, directs overarching corporate strategy and operational frameworks. Marsland guides the company's expansion into new markets and oversees the integration of innovative development methodologies. This leadership role ensures ICON's continued success in providing drug and device development services to pharmaceutical, biotechnology, medical device, and government organizations. By focusing on strategic partnerships and resource allocation, Thomas Marsland drives the company's mission to accelerate the commercialization of life-changing therapies. The President's purview encompasses global operational efficiency and long-term business planning, directly supporting the company's impact on public health initiatives worldwide.

Connie Inguanti, the President, Symphony Health at ICON, spearheads the strategic direction and operational execution for the Symphony Health division. Inguanti focuses on leveraging data analytics and technology to enhance drug and device development services for pharmaceutical and biotechnology clients. This leadership position involves optimizing commercialization strategies and ensuring seamless service delivery across North America and EMEA regions. By fostering innovation within Symphony Health, Connie Inguanti drives significant advancements in market access and patient outcomes. The President, Symphony Health's responsibilities include cultivating key client relationships and expanding the division's service portfolio to meet evolving industry demands, directly contributing to ICON's market leadership.

Deepali Suri, the President, ICON Biotech at ICON, directs the specialized services for the biotechnology sector. Suri architects strategies for complex drug development pipelines and device commercialization, ensuring ICON Biotech remains at the forefront of scientific advancement. This executive role involves managing cross-functional teams to deliver tailored solutions that accelerate therapeutic innovation. By focusing on operational excellence and client-centric approaches, Deepali Suri enhances ICON's capacity to support emerging biotechnology firms and established industry leaders. The President, ICON Biotech's leadership ensures the division effectively navigates regulatory landscapes and market dynamics, reinforcing ICON's commitment to global health solutions.

Marian Colon-Nieves, the Manager, Clinical Operations & Chief People Officer at ICON, oversees critical aspects of human capital management and the execution of clinical trial operations. Colon-Nieves ensures the development and implementation of robust people strategies that support ICON's global workforce, fostering a culture of excellence and compliance. Simultaneously, this leadership role directs the efficient management of clinical operations, ensuring the successful delivery of drug and device development services. By aligning human resources with operational objectives, Marian Colon-Nieves enhances ICON's ability to attract, retain, and develop top talent. The Manager, Clinical Operations & Chief People Officer's dual focus drives both organizational effectiveness and the successful progression of client projects.